Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?
Standard
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up? / Groetzner, J; Meiser, B M; Schirmer, J; Koglin, J; vScheidt, W; Klauss, V; Cremer, P; Reichenspurner, H; Reichart, B.
In: TRANSPL P, Vol. 33, No. 1-2, 27.03.2001, p. 1461-1464.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?
AU - Groetzner, J
AU - Meiser, B M
AU - Schirmer, J
AU - Koglin, J
AU - vScheidt, W
AU - Klauss, V
AU - Cremer, P
AU - Reichenspurner, H
AU - Reichart, B
PY - 2001/3/27
Y1 - 2001/3/27
KW - Adult
KW - Creatinine/blood
KW - Cyclosporine/adverse effects
KW - Diabetes Mellitus/chemically induced
KW - Female
KW - Follow-Up Studies
KW - Graft Rejection/epidemiology
KW - Heart Transplantation/immunology
KW - Humans
KW - Hyperlipidemias/chemically induced
KW - Hypertension/chemically induced
KW - Immunosuppressive Agents/adverse effects
KW - Incidence
KW - Kidney Diseases/chemically induced
KW - Male
KW - Middle Aged
KW - Prospective Studies
KW - Tacrolimus/adverse effects
U2 - 10.1016/s0041-1345(01)01906-6
DO - 10.1016/s0041-1345(01)01906-6
M3 - SCORING: Journal article
C2 - 11267373
VL - 33
SP - 1461
EP - 1464
JO - TRANSPL P
JF - TRANSPL P
SN - 0041-1345
IS - 1-2
ER -